abstract |
The invention relates to the PPAR-alpha activating compounds of general formula (I), for treating for example coronary heart diseases, and to a method for producing said compounds, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, A and X are defined as in claim 1. |